Press Releases

Mar 22, 2016

New Study Supports Use of Veracyte's Medullary Thyroid Cancer Classifier as Part of Its Comprehensive Afirma Solution

Read More

Mar 16, 2016

New Data Show That Veracyte's Afirma® Gene Expression Classifier Reduces Unnecessary Thyroid Surgeries and Costs During Long-Term Follow-Up

Read More

Mar 10, 2016

Veracyte Announces Fourth Quarter and Full-Year 2015 Financial Results, Provides 2016 Financial Outlook

Read More

Feb 29, 2016

Veracyte Announces Publication of Data Confirming Analytical Verification of Percepta® Bronchial Genomic Classifier

Read More

Feb 25, 2016

Veracyte Announces Publication of Data Supporting Clinical Utility of the Percepta® Bronchial Genomic Classifier in Lung Cancer Diagnosis

Read More

Feb 25, 2016

Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2015 Financial Results on March 10

Read More

Feb 19, 2016

Veracyte Announces Publication of Study Reinforcing the Clinical Utility of the Afirma® Gene Expression Classifier in Thyroid Cancer Diagnosis

Read More

Jan 28, 2016

Veracyte Receives Regulatory Authorization to Offer Percepta™ Bronchial Genomic Classifier for Patients in New York State

Read More

Jan 27, 2016

Veracyte to Participate in Two Upcoming Investor Conferences

Read More

Jan 22, 2016

Veracyte Announces Publication of Long-Term Clinical Utility Study for the Afirma® Gene Expression Classifier

Read More